TrialJAMA network open2023

Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical Trial.

Ehsan Mostafavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.